Emblem Corp: Financial Performance Highlights Sustainable Growth

    Author Siraj SarwarPosted on Categories CannabisTags , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
    Emblem Corp

    Emblem Corp (OTCPK:EMMBF) -a licensed producer of medical cannabis, continues to enhance trader’s confidence with its strong financial numbers. The company first-quarter revenue and earnings improved substantially from the year-ago period. This is due to the company’s strategy of expanding its cannabis oil business combined with continued growth from the sales of dried flowers.

    Emblem Corp: First Quarter Results

    Its revenue of $1.3 million in the first quarter increased 41% from the year-ago period. The company’s sale total of dried-flower to medical patients amounted to 52.8 kilograms. The total dried flower sold to licensed producers stood at around 71.1 kilograms.

    In addition, revenue from cannabis oil came in at around $187,000 in the first quarter. Its cannabis oil revenue accounted for 29% of the total revenue. The company’s management is optimistic regarding its oil business in the following quarters.

    Nick Dean, President & CEO of Emblem Corp said, “Our oils now represent close to one-third of our total patient sales.  As we continue to introduce new dose-controlled formats and sizes to the market, we expect this trend will continue upward.”

    Its gross margin rose 300% from the year-ago period, supported by higher revenue and better-unrealized gain on changes in fair value of biological assets.

    The Outlook for the Rest of the Year

    Emblem’s stable cash position has been allowing it to execute its growth plans. Its cash position stood at around $83.8 million at the end of the first quarter. The growth in cash position was due to the financing of $53.8 million in the latest quarter.

    >>Cannabis Stock News: The Latest on Cannabis Wheaton and Nutritional High

    The company expects to enhance its annual production capacity to 17,000kg to capitalize on increasing demand from medical and recreational markets. Emblem Corp has also been making investments in clinical research, pharmaceutical research, marketing, and promotion to sustain and expand its markets share in the rapidly growing cannabis industry.

    Featured Image: Depositphotos/© merznatalia

    Author Siraj Sarwar
    About the author: Based in Saudi Arabia, Siraj has a strong understanding of and passion for accounting and finance. He has worked for international clients for many years on several projects related to the stock market, equity research and other business, accounting and finance related projects. Siraj is a published financial analyst on the world's leading websites including SeekingAlpha, TheStreet, MSN, and others.